These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 981785)

  • 21. [Chronopharmacokinetics of phenylbutazone in the horse. Application to antidoping control].
    Jaussaud P; Courtot D; Doron P; Guyot JL
    Ann Rech Vet; 1985; 16(4):385-91. PubMed ID: 4091494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratracheal clenbuterol in the horse: its pharmacological efficacy and analytical detection.
    Harkins JD; Robinson NE; Woods WE; Lehner AF; Smith MD; Gates RS; Fisher M; Tobin T
    J Vet Pharmacol Ther; 2000 Aug; 23(4):251-60. PubMed ID: 11106998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of furosemide on urine specific gravity and osmolality in thoroughbred racehorses.
    Bosken JM; Tobin T; Mundy GD; Fisher M; Gantz MG; Banks RO
    Vet Ther; 2003; 4(3):292-8. PubMed ID: 15136991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-isotopic immunoassay drug tests in racing horses: a review of their application to pre- and post-race testing, drug quantitation, and human drug testing.
    Tobin T; Watt DS; Kwiatkowski S; Tai HH; Blake JW; McDonald J; Prange CA; Wie S
    Res Commun Chem Pathol Pharmacol; 1988 Dec; 62(3):371-95. PubMed ID: 3065859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of diuretics after pretreatment with reserpine and 6-OH-dopamine (author's transl)].
    Hörl WH; Hennemann HM; Heidland A
    Arzneimittelforschung; 1976 Apr; 26(4):539-43. PubMed ID: 989009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of phenylbutazone in neonatal foals.
    Wilcke JR; Crisman MV; Sams RA; Gerken DF
    Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute hemodynamic effects of furosemide administered intravenously in the horse.
    Muir WW; Milne DW; Skarda RT
    Am J Vet Res; 1976 Oct; 37(10):1177-80. PubMed ID: 984543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of furosemide on plasma atrial natriuretic peptide and aldosterone concentrations and renin activity in running horses.
    Cooley JL; Hinchcliff KW; McKeever KH; Lamb DR; Muir WW
    Am J Vet Res; 1994 Feb; 55(2):273-7. PubMed ID: 8172419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.
    Chay S; Woods WE; Rowse K; Nugent TE; Blake JW; Tobin T
    Drug Metab Dispos; 1983; 11(3):226-31. PubMed ID: 6135581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous analysis of furosemide and bumetanide in horse plasma using high performance liquid chromatography.
    Singh AK; McArdle C; Gordon B; Ashraf M; Granley K
    Biomed Chromatogr; 1989 Nov; 3(6):262-5. PubMed ID: 2620147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of phenylbutazone and anabolic steroids on adrenal and thyroid gland function tests in healthy horses.
    Morris DD; Garcia MC
    Am J Vet Res; 1985 Feb; 46(2):359-64. PubMed ID: 3994102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of flurbiprofen on the responses to frusemide in healthy volunteers.
    Symmons DP; Kendall MJ; Rees JA; Hind ID
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):350-4. PubMed ID: 6885206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection, quantification, and pharmacokinetics of furosemide and its effects on urinary specific gravity following IV administration to horses.
    Dirikolu L; Lehner AF; Hughes C; Karpiesiuk W; Camargo FC; Harkins JD; Woods WE; Bosken JM; Boyles J; Troppmann A; Fisher M; Tobin T
    Vet Ther; 2003; 4(4):350-63. PubMed ID: 15136977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral cimetidine on plasma concentrations of phenylbutazone in horses.
    Christensen JM; Blythe LL; Craig AM
    J Vet Pharmacol Ther; 1985 Dec; 8(4):404-12. PubMed ID: 4094031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
    Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.